Pediatr Diabetes 10(Suppl 12):118133 Yang Z, Yu M, Mei M, Chen C, Lv Y, Xiang L et al (2022) The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system
PMID: 41880199 Zeng K et al
These are the concentrations that produce the cleanest unit numbers across the widest range of doses
for unhealthy individuals with some extra weight, most forms of trimming down will help
The limited understanding of the underlying biosynthetic mechanisms further complicates optimization, as many studies only infer the roles of plant extracts (e.g., reducing, capping, or chelating agents) without detailing specific chemical pathways (Ying et al., 2022)
Weight loss may begin during the first month, though this varies considerably between individuals